Breadcrumb

CTB News

Unravelling mechanisms for cardiovascular therapeutics

RI-MUHC researchers co-lead a team that combines novel pharmacology with structural biology and computational modelling to discover new domains...

Collaborating with industry to develop lipid nanoparticles

RI-MUHC researcher Julia Burnier heads one of two projects selected for funding by Moderna

Clinical research thrives in Montreal’s West Island

The MUHC Vaccine Study Centre has been conducting top quality vaccine and epidemiological research studies for more than 30 years

New research aims to make prostate cancer prognostics more precise

A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer

New advances in lung cancer treatment

Results of an international clinical trial confirm the efficiency of an immunotherapy treatment for early stage non-small cell lung cancer

Exosomes, vesicles and particles are no longer obscure

The launch of the Centre for Applied Nanomedicine at the RI-MUHC opens an ecosystem of possibilities to the research community

RI-MUHC technology platforms form new partnerships to accelerate research and drug discovery

Partnerships between NMX Research and Solutions, the RI-MUHC...

IDIGH Program gathers at the Glen site for seventh annual research day

Researchers and trainees from the Infectious Diseases and Immunity in Global Health Program at the RI-MUHC enjoyed a stimulating day...

RI-MUHC researchers identify new autophagy-regulating gene

Researchers report how they were able to identify a previously unknown gene involved in regulating autophagy and skeletal muscle integrity

RI-MUHC researchers contribute to two seminal studies of lung and brain cancer

These studies published in Nature demonstrate how big data and artificial intelligence are the future of cancer...

Explore news and events at the RI-MUHC